Concourse Financial Group Securities, Inc. P Lx Pharma Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share
Q1 2023 May 15, 2023	BUY	$0.12 - $0.3 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.15 - $0.63 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.52 - $3.08 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.9 - $4.18 $0 - $0
Q1 2022 May 09, 2022	BUY	$3.54 - $8.3 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$7.69 - $19.66 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$12.22 - $21.28 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$9.0 - $15.94 $0 - $0
Q1 2021 May 13, 2021	BUY	$5.24 - $10.14 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$3.01 - $6.7 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$2.83 - $4.21 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$2.32 - $4.02 $0 - $0
Q1 2020 May 13, 2020	BUY	$1.98 - $5.87 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.36 - $5.04 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$4.89 - $7.18 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$4.93 - $7.2 $0 - $0
Q1 2019 May 15, 2019	BUY	$2.05 - $6.0 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$1.22 - $4.38 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$3.18 - $5.15 $0 - $0

Others Institutions Holding PLXP

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About PLx Pharma Inc.

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

More about PLXP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account